搜索结果 | 泌尿系统常见疾病循证医学证据

证据分类

搜索结果

共搜索到81条与Transitional Cell有关的结果

Reduced- vs full-dose BCG in bladder cancer: A systematic review and meta-analysis

 2023 年发布于 Actas Urol Esp (Engl Ed) 95 卷第 6 期

Verri P. Baboudjian M. Diana P. Gallioli A. Territo A. Gaya J. M. Huguet J. Rodriguez-Faba O. Palou J. Breda A.

Humans Smoking/adverse effects/epidemiology *Non-Muscle Invasive Bladder Neoplasms *Urinary Bladder Neoplasms/epidemiology/etiology *Carcinoma Transitional Cell Prognosis Neoplasm Recurrence Local/epidemiology Current smoker Non-muscle-invasive bladder cancer Progression Recurrence Smoking
文献简介 原文链接
The impact of smoking on recurrence and progression of non-muscle invasive bladder cancer: a systematic review and meta-analysis

 2023 年发布于 J Cancer Res Clin Oncol 37 卷第 6 期

Ślusarczyk A. Zapała P. Zapała Ł Radziszewski P.

Humans Female *Urinary Bladder Neoplasms/pathology *Carcinoma Transitional Cell/pathology Urinary Bladder/pathology Prognosis Proportional Hazards Models Meta-analysis Muscle-invasive bladder urothelial carcinoma Non-muscle-invasive bladder urothelial carcinoma Sex
文献简介 原文链接
Systematic review of reported association studies of monogenic genes and bladder cancer risk and confirmation analysis in a large population cohort

 2023 年发布于 BJUI Compass 21 卷第 1 期

Mian A. Wei J. Shi Z. Rifkin A. S. Zheng S. L. Glaser A. P. Kearns J. T. Helfand B. T. Xu J.

Humans Immune Checkpoint Inhibitors/therapeutic use *Carcinoma Transitional Cell/drug therapy *Urinary Bladder Neoplasms/drug therapy Proportional Hazards Models Eastern Cooperative Oncology Group Immune checkpoint inhibitor Performance status Urothelial carcinoma
文献简介 原文链接
Comparison of different methods of obturator nerve block in transurethral resection of bladder tumors: A systematic review and network meta-analysis

 2023 年发布于 Cancer Med 27 卷第 4 期

Wu J. Gao Y. Xiong Z. Xiao X. Yang J. Yang X. Huang Y.

Humans *Carcinoma Transitional Cell/drug therapy *Urinary Bladder Neoplasms/pathology *Urologic Neoplasms/drug therapy/pathology Antibodies Monoclonal/adverse effects
文献简介 原文链接
Relative Risk of Bladder and Kidney Cancer in Lynch Syndrome: Systematic Review and Meta-Analysis

 2023 年发布于 Cancers 41 卷第 6 期

Nassour A. J. Jain A. Hui N. Siopis G. Symons J. Woo H.

Humans *Urinary Bladder Neoplasms *Carcinoma Transitional Cell/surgery/pathology Ureteroscopy/adverse effects/methods *Ureteral Neoplasms/surgery/pathology *Kidney Neoplasms/surgery/pathology Antegrade Endoscopic surgery Kidney-sparing surgery Retrograde Upper tract urothelial carcinoma
文献简介 原文链接
Blood-Based Biomarkers as Prognostic Factors of Recurrent Disease after Radical Cystectomy: A Systematic Review and Meta-Analysis

 2023 年发布于 Int J Mol Sci 41 卷第 2 期

Ofner H. Laukhtina E. Hassler M. R. Shariat S. F.

Humans *Carcinoma Transitional Cell/pathology *Urinary Bladder Neoplasms/genetics DNA Methylation Neoplasm Recurrence Local/genetics Prognosis *Urologic Neoplasms/genetics/pathology Membrane Proteins/genetics Neoplasm Proteins/genetics Biomarkers Kaplan-Meier survival Meta-analysis Methylation Upper tract urothelial carcinoma
文献简介 原文链接
Postoperative Mortality Rate after Radical Cystectomy: A Systematic Review of Epidemiologic Series

 2023 年发布于 Urol Int 75 卷第 4 期

Korkes F. Timoteo F. Baccaglini W. Glina F. Faba O. R. Palou Redorta J. Glina S.

Humans Female *Carcinoma Transitional Cell/chemically induced/epidemiology/genetics DNA Adducts/adverse effects *Drugs Chinese Herbal/adverse effects Taiwan/epidemiology *Urinary Bladder Neoplasms Carcinogens *Kidney Neoplasms/chemically induced/epidemiology/genetics *Aristolochic Acids/adverse effects/analysis *Ureteral Neoplasms/chemically induced/epidemiology *Urinary Tract Aristolochia DNA adduct Mass spectrometry Nephropathy Renal pelvic cancer Ureteral cancer
文献简介 原文链接
The Effect of Metformin on Bladder Cancer Incidence and Outcomes: A Systematic Review and Meta-Analysis

 2022 年发布于 Urol Oncol 46 卷第 2 期

van Hattum J. W. de Ruiter B. Oddens J. R. de Reijke T. M. Wilmink J. W. Molenaar R. J.

*Carcinoma Transitional Cell/drug therapy Humans Organoids Precision Medicine *Urinary Bladder Neoplasms/drug therapy Urothelium/pathology Metastases Personalized medicine Stem cells Transurethral resection
文献简介 原文链接
Dietary consumption of cruciferous vegetables and bladder cancer risk: A systematic review and meta-analysis

 2022 年发布于 Int J Clin Oncol 191 卷第 17 期

Yu P. Yu L. Lu Y.

Humans *Carcinoma Transitional Cell *Urinary Bladder Neoplasms/pathology Retrospective Studies BCG Vaccine/therapeutic use Administration Intravesical Adjuvants Immunologic *Organ Transplantation Neoplasm Invasiveness Neoplasm Recurrence Local/pathology Bcg Bladder cancer Chemotherapy Mitomycin Transplanted patients
文献简介 原文链接
En Bloc Resection for Bladder Tumors: An Updated Systematic Review and Meta-Analyses of Its Differential Effect on Its Safety, Histopathology and, Recurrence

 2022 年发布于 Bladder Cancer 81 卷第 6 期

Yanagisawa T. Mori K. Motlagh R. S. Kawada T. Mostafaei H. Quhal F. Laukhtina E. Rajwa P. Konig F. Pallauf M. Pradere B. D'Andrea D. Comperat E. Miki J. Kimura T. Egawa S. Shariat S. F.

Aged Antineoplastic Combined Chemotherapy Protocols/*therapeutic use Carcinoma Transitional Cell/*drug therapy/*pathology Female Humans Immune Checkpoint Inhibitors/*therapeutic use Liver Neoplasms/secondary Male Middle Aged Survival Analysis Urinary Bladder Neoplasms/*drug therapy/*pathology bladder cancer immune checkpoint inhibitors immunotherapy meta-analysis urothelial carcinoma
文献简介 原文链接
P3H4 and PLOD1 expression associates with poor prognosis in bladder cancer

 2022 年发布于 Medicine 50 卷第 3 期

Zhang J. Dong Y. Shi Z. He H. Chen J. Zhang S. Wu W. Zhang Q. Han C. Hao L.

*Carcinoma Transitional Cell Humans Prognosis Retrospective Studies *Urinary Bladder Neoplasms/surgery *Urinary Tract
文献简介 原文链接
Decreased Preoperative Serum AGR as a Diagnostic Marker of Poor Prognosis after Radical Surgery of Upper Urinary Tract and Bladder Cancers from a Pooled Analysis of 9,002 Patients

 2022 年发布于 World J Urol 32 卷第 9 期

Wang X. Yang G. Chai Y. Li Z. Che X. Wang Y. Yang L. Zhou Z.

Humans Carboplatin/therapeutic use *Carcinoma Transitional Cell/drug therapy *Urinary Bladder Neoplasms Carboplatin Cisplatin Immune checkpoint inhibitors Platinum-based chemotherapy Urothelial carcinoma
文献简介 原文链接
Adjuvant Radiotherapy for Upper Tract Urothelial Carcinoma: Systematic Review and Meta-Analysis

 2022 年发布于 BJU Int 8 卷第 4 期

Zalay O. Yan M. Sigurdson S. Malone S. Vera-Badillo F. E. Mahmud A.

Biomarkers Tumor *Carcinoma Transitional Cell/diagnosis Female Humans Male Nuclear Proteins Sensitivity and Specificity *Urinary Bladder Neoplasms/diagnosis/pathology bladder tumor diagnosis meta analysis nuclear matrix protein urine cytology
文献简介 原文链接
Inter-reader reliability of the vesical imaging-reporting and data system (VI-RADS) for muscle-invasive bladder cancer: a systematic review and meta-analysis

 2022 年发布于 Bladder Cancer 2022 卷第 5 期

Jazayeri S. B. Dehghanbanadaki H. Hosseini M. Taghipour P. Bazargani S. Thomas D. Feibus A. Sarabchian E. Bacchus M. W. Di Valerio E. A. Bandyk M. Balaji K. C.

Area Under Curve *Carcinoma Transitional Cell Humans In Situ Hybridization Fluorescence ROC Curve Sensitivity and Specificity *Urinary Bladder Neoplasms/pathology Biomarker Cytology Diagnostic Fluorescent in situ hybridization (FISH) Meta-analysis Upper urinary tract urothelial carcinoma (UTUC)
文献简介 原文链接
The clinical efficacy and safety of equipment-assisted intravesical instillation of mitomycin C after transurethral resection of bladder tumour in patients with nonmuscular invasive bladder cancer: A meta-analysis

 2022 年发布于 Int J Urol 86 卷第 1 期

Zhou W. Liu J. Mao D. Hu C. Gao D.

Antibodies Monoclonal Humanized/*therapeutic use *Carcinoma Transitional Cell/drug therapy Humans Prognosis Retrospective Studies *Urinary Bladder Neoplasms/drug therapy Metastatic urothelial carcinoma Pembrolizumab Prognostic factor Janssen and Pfizer. Takahiro Kimura is a paid consultant/advisor of Astellas Bayer Janssen and Sanofi. Shahrokh F. Shariat is a paid as follows: Honoraria: Astellas AstraZeneca Bayer BMS Cepheid Ferring Ipsen Janssen Lilly MSD Olympus Pfizer Pierre Fabre Richard Wolf Roche Sanochemia Sanofi Takeda Urogen. Consulting or Advisory Role: Astellas AstraZeneca Bayer BMS Cepheid Ferring Ipsen Janssen Lilly MSD Olympus Pfizer Pierre Fabre Richard Wolf Roche Sanochemia Sanofi Takeda Urogen. Speakers Bureau: Astellas Astra Zeneca Bayer BMS Cepheid Ferring Ipsen Janssen Lilly MSD Olympus Pfizer Pierre Fabre Richard Wolf Roche Sanochemia Sanofi Takeda Urogen Movember Foundation. The other authors declare no conflicts of interest associated with this manuscript.
文献简介 原文链接
The prognostic significance of controlling nutritional status (CONUT) score for surgically treated renal cell cancer and upper urinary tract urothelial cancer: a systematic review and meta-analysis

 2022 年发布于 PLoS One 104 卷第 7 期

Peng L. Meng C. Li J. You C. Du Y. Xiong W. Xia Z. Cao D. Li Y.

Humans Female Male Infant *Urinary Bladder Neoplasms/diagnosis/therapy/pathology *Carcinoma Transitional Cell/pathology Urinary Bladder/pathology Neoplasm Staging Cystoscopy Cystectomy/methods
文献简介 原文链接
Pretreatment clinical and hematologic prognostic factors of metastatic urothelial carcinoma treated with pembrolizumab: a systematic review and meta-analysis

 2022 年发布于 African Journal of Urology 52 卷第 6 期

Yanagisawa T. Mori K. Katayama S. Mostafaei H. Quhal F. Laukhtina E. Rajwa P. Motlagh R. S. Aydh A. König F. Grossmann N. C. Pradere B. Miki J. Kimura T. Egawa S. Shariat S. F.

*Carcinoma Renal Cell/complications/epidemiology *Carcinoma Transitional Cell/complications/epidemiology Cross-Sectional Studies Hematuria/epidemiology/etiology Humans Incidence *Kidney Neoplasms/complications/epidemiology Male Prospective Studies Retrospective Studies Risk Factors *Urinary Bladder Neoplasms/complications/epidemiology Age distribution Cystoscopy Haematuria Kidney neoplasms Radiotherapy Sex Smoking Transitional cell carcinoma Urinary bladder neoplasms Urological neoplasms
文献简介 原文链接
Intravesical Therapy in Patients with Intermediate-risk Non-muscle-invasive Bladder Cancer: A Systematic Review and Network Meta-analysis of Disease Recurrence

 2022 年发布于 Infect Agent Cancer 11 卷第 3 期

Laukhtina E. Abufaraj M. Al-Ani A. Ali M. R. Mori K. Moschini M. Quhal F. Sari Motlagh R. Pradere B. Schuettfort V. M. Mostafaei H. Katayama S. Grossmann N. C. Fajkovic H. Soria F. Enikeev D. Shariat S. F.

Humans *Carcinoma Renal Cell/surgery Prognosis Nutritional Status *Carcinoma Transitional Cell/surgery *Urinary Bladder Neoplasms Nephrectomy *Kidney Neoplasms/surgery Retrospective Studies Controlling Nutritional Status score Renal cell carcinoma Upper tract urothelial carcinoma
文献简介 原文链接
Can a reresection be avoided after initial en bloc resection for high-risk nonmuscle invasive bladder cancer? A systematic review and meta-analysis

 2022 年发布于 Irish Journal of Medical Science 36 卷第 6 期

Xu J. Xu Z. Yin H. Zang J.

*Antineoplastic Agents/adverse effects *Carcinoma Transitional Cell/drug therapy Humans Mutation Receptor ErbB-2 Trastuzumab/adverse effects *Urinary Bladder Neoplasms/drug therapy Erbb2 Her2 Metastatic bladder cancer Metastatic urothelial cancer Targeted treatment
文献简介 原文链接
热疗联合化疗治疗中、高危非肌层浸润性膀胱癌有效性及安全性的 meta 分析

 2022 年发布于 PLoS One 29 卷第 39 期

李佳坤

Humans *Carcinoma Transitional Cell/radiotherapy/surgery/drug therapy *Urinary Bladder Neoplasms Radiotherapy Adjuvant Retrospective Studies Prospective Studies Neoplasm Recurrence Local adjuvant radiotherapy external beam genitourinary locoregional control meta-analysis proximal ureter renal pelvis survival systematic review upper tract urothelial carcinoma
文献简介 原文链接

 2023 年 发布于 Actas Urol Esp (Engl Ed) 95 卷 第 6 期

Verri P. Baboudjian M. Diana P. Gallioli A. Territo A. Gaya J. M. Huguet J. Rodriguez-Faba O. Palou J. Breda A.

 2023 年 发布于 J Cancer Res Clin Oncol 37 卷 第 6 期

Ślusarczyk A. Zapała P. Zapała Ł Radziszewski P.

 2023 年 发布于 BJUI Compass 21 卷 第 1 期

Mian A. Wei J. Shi Z. Rifkin A. S. Zheng S. L. Glaser A. P. Kearns J. T. Helfand B. T. Xu J.

 2023 年 发布于 Cancer Med 27 卷 第 4 期

Wu J. Gao Y. Xiong Z. Xiao X. Yang J. Yang X. Huang Y.

 2023 年 发布于 Cancers 41 卷 第 6 期

Nassour A. J. Jain A. Hui N. Siopis G. Symons J. Woo H.

 2023 年 发布于 Int J Mol Sci 41 卷 第 2 期

Ofner H. Laukhtina E. Hassler M. R. Shariat S. F.

 2023 年 发布于 Urol Int 75 卷 第 4 期

Korkes F. Timoteo F. Baccaglini W. Glina F. Faba O. R. Palou Redorta J. Glina S.

 2022 年 发布于 Urol Oncol 46 卷 第 2 期

van Hattum J. W. de Ruiter B. Oddens J. R. de Reijke T. M. Wilmink J. W. Molenaar R. J.

 2022 年 发布于 Int J Clin Oncol 191 卷 第 17 期

Yu P. Yu L. Lu Y.

 2022 年 发布于 Bladder Cancer 81 卷 第 6 期

Yanagisawa T. Mori K. Motlagh R. S. Kawada T. Mostafaei H. Quhal F. Laukhtina E. Rajwa P. Konig F. Pallauf M. Pradere B. D'Andrea D. Comperat E. Miki J. Kimura T. Egawa S. Shariat S. F.

 2022 年 发布于 Medicine 50 卷 第 3 期

Zhang J. Dong Y. Shi Z. He H. Chen J. Zhang S. Wu W. Zhang Q. Han C. Hao L.

 2022 年 发布于 World J Urol 32 卷 第 9 期

Wang X. Yang G. Chai Y. Li Z. Che X. Wang Y. Yang L. Zhou Z.

 2022 年 发布于 BJU Int 8 卷 第 4 期

Zalay O. Yan M. Sigurdson S. Malone S. Vera-Badillo F. E. Mahmud A.

 2022 年 发布于 Bladder Cancer 2022 卷 第 5 期

Jazayeri S. B. Dehghanbanadaki H. Hosseini M. Taghipour P. Bazargani S. Thomas D. Feibus A. Sarabchian E. Bacchus M. W. Di Valerio E. A. Bandyk M. Balaji K. C.

 2022 年 发布于 Int J Urol 86 卷 第 1 期

Zhou W. Liu J. Mao D. Hu C. Gao D.

 2022 年 发布于 PLoS One 104 卷 第 7 期

Peng L. Meng C. Li J. You C. Du Y. Xiong W. Xia Z. Cao D. Li Y.

 2022 年 发布于 African Journal of Urology 52 卷 第 6 期

Yanagisawa T. Mori K. Katayama S. Mostafaei H. Quhal F. Laukhtina E. Rajwa P. Motlagh R. S. Aydh A. König F. Grossmann N. C. Pradere B. Miki J. Kimura T. Egawa S. Shariat S. F.

 2022 年 发布于 Infect Agent Cancer 11 卷 第 3 期

Laukhtina E. Abufaraj M. Al-Ani A. Ali M. R. Mori K. Moschini M. Quhal F. Sari Motlagh R. Pradere B. Schuettfort V. M. Mostafaei H. Katayama S. Grossmann N. C. Fajkovic H. Soria F. Enikeev D. Shariat S. F.

 2022 年 发布于 Irish Journal of Medical Science 36 卷 第 6 期

Xu J. Xu Z. Yin H. Zang J.

 2022 年 发布于 PLoS One 29 卷 第 39 期

李佳坤

 2023 年发布于 Actas Urol Esp (Engl Ed) 95 卷第 6 期

 2023 年发布于 J Cancer Res Clin Oncol 37 卷第 6 期

 2023 年发布于 BJUI Compass 21 卷第 1 期

 2023 年发布于 Cancer Med 27 卷第 4 期

 2023 年发布于 Cancers 41 卷第 6 期

 2023 年发布于 Int J Mol Sci 41 卷第 2 期

 2023 年发布于 Urol Int 75 卷第 4 期

 2022 年发布于 Urol Oncol 46 卷第 2 期

 2022 年发布于 Int J Clin Oncol 191 卷第 17 期

 2022 年发布于 Bladder Cancer 81 卷第 6 期

 2022 年发布于 Medicine 50 卷第 3 期

 2022 年发布于 World J Urol 32 卷第 9 期

 2022 年发布于 BJU Int 8 卷第 4 期

 2022 年发布于 Bladder Cancer 2022 卷第 5 期

 2022 年发布于 Int J Urol 86 卷第 1 期

 2022 年发布于 PLoS One 104 卷第 7 期

 2022 年发布于 African Journal of Urology 52 卷第 6 期

 2022 年发布于 Infect Agent Cancer 11 卷第 3 期

 2022 年发布于 Irish Journal of Medical Science 36 卷第 6 期

 2022 年发布于 PLoS One 29 卷第 39 期